These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2937908

  • 1. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE, Sprugel KH, Hadley KB, Roth RA.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [Abstract] [Full Text] [Related]

  • 2. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
    Hilliker KS, Bell TG, Roth RA.
    Thromb Haemost; 1983 Dec 30; 50(4):844-7. PubMed ID: 6665765
    [Abstract] [Full Text] [Related]

  • 3. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
    Bruner LH, Johnson K, Carpenter LJ, Roth RA.
    J Toxicol Environ Health; 1987 Dec 30; 21(1-2):205-17. PubMed ID: 3573071
    [Abstract] [Full Text] [Related]

  • 4. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jul 30; 121(1):129-37. PubMed ID: 7687795
    [Abstract] [Full Text] [Related]

  • 5. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
    Schultze AE, Gunaga KP, Wagner JG, Hoorn CM, Moorehead WR, Roth RA.
    Toxicol Appl Pharmacol; 1994 Jun 30; 126(2):301-10. PubMed ID: 8209383
    [Abstract] [Full Text] [Related]

  • 6. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
    Hilliker KS, Garcia CM, Roth RA.
    Res Commun Chem Pathol Pharmacol; 1983 May 30; 40(2):179-97. PubMed ID: 6410470
    [Abstract] [Full Text] [Related]

  • 7. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS, Bell TG, Lorimer D, Roth RA.
    Am J Physiol; 1984 Jun 30; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [Abstract] [Full Text] [Related]

  • 8. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jul 30; 109(3):421-31. PubMed ID: 1830177
    [Abstract] [Full Text] [Related]

  • 9. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Toxicol Appl Pharmacol; 1987 Apr 30; 88(2):157-64. PubMed ID: 3564035
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
    Hilliker KS, Roth RA.
    Am Rev Respir Dis; 1985 Jan 30; 131(1):46-50. PubMed ID: 3966714
    [Abstract] [Full Text] [Related]

  • 13. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
    Ganey PE, Fink GD, Roth RA.
    Toxicol Appl Pharmacol; 1985 Mar 30; 78(1):55-62. PubMed ID: 2930913
    [Abstract] [Full Text] [Related]

  • 14. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I, Nobler MS, Frazer A.
    J Pharmacol Exp Ther; 1984 Jan 30; 228(1):133-9. PubMed ID: 6694097
    [Abstract] [Full Text] [Related]

  • 15. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
    Hilliker KS, Roth RA.
    Br J Pharmacol; 1984 Jun 30; 82(2):375-80. PubMed ID: 6234044
    [Abstract] [Full Text] [Related]

  • 16. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC, Wilson DW, Lamé MW, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1993 Jan 30; 118(1):87-97. PubMed ID: 8430429
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Ganey PE, Sprugel KH, White SM, Wagner JG, Roth RA.
    Am J Physiol; 1988 Nov 30; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
    [Abstract] [Full Text] [Related]

  • 18. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE, Roth RA.
    J Toxicol Environ Health; 1988 Nov 30; 23(1):127-37. PubMed ID: 3336057
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats.
    White SM, Roth RA.
    Toxicol Appl Pharmacol; 1988 Dec 30; 96(3):465-75. PubMed ID: 2974653
    [Abstract] [Full Text] [Related]

  • 20. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Roth RA, Ganey PE.
    Toxicol Appl Pharmacol; 1988 May 30; 93(3):463-71. PubMed ID: 3130680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.